Cipla therapeutics and siga technologies announce strategic partnership to support innovation and provide access to novel antibacterial drugs against biothreats

New york, march 23, 2021 (globe newswire) -- cipla therapeutics, a division of cipla usa inc., an affiliate of cipla limited (bse: 500087; nse: cipla eq; referred to as "cipla") and siga technologies, inc. (siga) (nasdaq: siga), a commercial-stage pharmaceutical company focused on the health security market announced entering into a strategic partnership to deliver sustained innovation and access to novel antibacterial drugs, particularly against biothreats.
SIGA Ratings Summary
SIGA Quant Ranking